B. Ngoumou

Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls.

P. Hardt, H. Kloer, M. Toepler, 2003, Anticancer research.

Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer.

P. Hardt, H. Schnell-Kretschmer, H. Kloer, 2000, Anticancer research.

Fecal pyruvate kinase concentrations (ELISA based on a combination of clone 1 and clone 3 antibodies) for gastric cancer screening.

P. Hardt, H. Kloer, M. Toepler, 2003, Anticancer research.